Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Title:
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Author:
Kwo, Paul Y Lawitz, Eric J McCone, Jonathan Schiff, Eugene R Vierling, John M Pound, David Davis, Mitchell N Galati, Joseph S Gordon, Stuart C Ravendhran, Natarajan Rossaro, Lorenzo Anderson, Frank H Jacobson, Ira M Rubin, Raymond Koury, Kenneth Pedicone, Lisa D Brass, Clifford A Chaudhri, Eirum Albrecht, Janice K